(Bloomberg) -- Color Genomics Inc., the DNA-testing company with $150 million in backing from investors including billionaire Laurene Powell Jobs and venture-capital firm General Catalyst, is partnering with NorthShore University HealthSystem to offer its genetic tests to more than 10,000 patients.
Key Insights
- The DNA-testing startup has been moving away from marketing directly to individual patients.
- As part of the collaboration, the Chicago hospital system will offer Color's genomic health tests to more than 10,000 patients as a primary-care service, rather than only to patients with genetic health risks. The goal is to incorporate genetic information throughout care.
Know More
- Color has existing partnerships with Illumina Inc. and the National Institutes of Health.
- Its $249 genetic test looks at a variety of genetic health factors, including cancer risk and how a patient's genes might affect reaction to some drugs. The consumer test will continue to be available.
To contact the reporter on this story: Kristen V. Brown in San Francisco at kbrown340@bloomberg.net
To contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Mark Schoifet
©2019 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
